Neuca (LTS:0MJR) ROCE %: 26.05% (As of Mar. 2026)


LTS:0MJR Neuca SA LTS:0MJR
97 GF Score
Price zł760.00
GF Value zł938.86
! 4 Warning Signs
View Full Analysis

What is Neuca ROCE %?

Neuca LTS:0MJR 97 ROCE % is 26.05% as of Mar. 2026. GuruFocus rates LTS:0MJR with a GF Score™ of 97/100 and a GF Value™ of zł938.86. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Neuca's annualized ROCE % for the quarter that ended in Mar. 2026 was 26.05%.

Neuca  (LTS:0MJR) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Neuca ROCE % Related Terms

Neuca ROCE % Historical Data

* Premium members only.

The historical data trend for Neuca's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neuca ROCE % Chart

Neuca Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.08 19.83 21.26 18.90 16.09

Neuca Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.01 12.72 22.01 10.63 26.05
LTS:0MJR
97GF Score
Neuca SA LTS:0MJR
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neuca ROCE % Calculation

Neuca's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=265.249/( ( (5510.182 - 3768.618) + (6242.08 - 4686.46) )/ 2 )
=265.249/( (1741.564+1555.62)/ 2 )
=265.249/1648.592
=16.09 %

Neuca's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=416.52/( ( (6242.08 - 4686.46) + (6135.546 - 4493.384) )/ 2 )
=416.52/( ( 1555.62 + 1642.162 )/ 2 )
=416.52/1598.891
=26.05 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 26.05% mean?
Neuca (LTS:0MJR) has a ROCE % of 26.05% as of Mar. 2026.
Is Neuca's ROCE % too high?
Neuca's current ROCE % is 26.05%. The Medical Distribution industry median ROCE % is 9.22. Neuca's value of 26.05% is 182.5% above this industry median. Overall, Neuca has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Neuca's ROCE % compare to MCK and COR?
Neuca's ROCE % of 26.05% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 9.22. Neuca's value of 26.05% is 182.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Distribution company?
The median ROCE % among Medical Distribution companies is 9.22, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neuca's current ROCE % of 26.05% is 182.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 9.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neuca's current ROCE % is 26.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neuca stock overvalued right now?
Neuca (LTS:0MJR) has a current ROCE % of 26.05%. The stock's GF Value™ is zł938.86, compared to a current price of zł760.00 — trading 19.1% below its estimated fair value. The current ROCE % is 26.05% and 182.5% above the Medical Distribution industry median of 9.22. Neuca's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Neuca (LTS:0MJR), the current ROCE % is 26.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neuca (LTS:0MJR) Overvalued in 2026?

Based on GuruFocus' analysis, Neuca stock appears to be undervalued. The current stock price of zł760.00 is trading 19.1% below its estimated GF Value™ of zł938.86.

Key valuation signals for LTS:0MJR:

  • ROCE %: 26.05%
  • GF Value™: zł938.86 vs. price of zł760.00 (19.1% below fair value)
  • GF Score™: 97/100 with 4 warning signs
  • Industry Position: 182.5% above the Medical Distribution median

No single metric tells the full story. See the LTS:0MJR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neuca Business Description

Other Exchanges NEU:Poland
Address ul. Forteczna 35‑37, Torun, POL, 87-100
Neuca SA is a wholesale distributor of pharmaceuticals in Poland. The company's segment includes Pharmacy wholesale; Manufacture of pharmaceuticals; Outpatient medical care clinics; Clinical trials and Insurance activities. It generates maximum revenue from the Pharmacy wholesale segment.
97GF Score

Get the complete analysis for LTS:0MJR

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł760.00
Price
zł938.86
GF Value